InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Catelani Michael, Chief Financial Officer. Insider active across 1 company, notably Anixa Biosciences Inc. In total, 14 disclosures have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €70k. History available since 30 April 2021. The latest transaction was filed on 15 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations14 total
9,289 shares@ US$2.1520.4% of flowCommon StockSEC:0001493152-25-002314:0
Ideal exit: 12 Oct 2025 (T+270)
6,250 shares@ US$2.4014.5% of flowCommon StockSEC:0001493152-24-023037:0
Ideal exit: 4 Mar 2025 (T+270)
1,189 shares@ US$2.523.0% of flowCommon StockSEC:0001493152-24-017496:0
1,117 shares@ US$2.693.0% of flowCommon StockSEC:0001493152-23-039093:0
5,500 shares@ US$3.6419.0% of flowCommon StockSEC:0001493152-23-025185:0
Ideal exit: 15 Apr 2024 (T+270)
865 shares@ US$3.472.9% of flowCommon StockSEC:0001493152-23-014890:0
1,069 shares@ US$2.813.2% of flowCommon StockSEC:0001493152-22-030070:0
1,086 shares@ US$2.760.0030% mcap8.8% of flowCommon StockSEC:0001493152-22-011741:0
5,500 shares@ US$2.660.014% mcap41.8% of flowCommon StockSEC:0001493152-22-010689:0
Ideal exit: 16 Jan 2023 (T+270)
2,509 shares@ US$2.530.0062% mcap18.1% of flowCommon StockSEC:0001493152-22-010594:0
Ideal exit: 15 Jan 2023 (T+270)
743 shares@ US$4.040.0027% mcap8.0% of flowCommon StockSEC:0001493152-21-026933:0
743 shares@ US$4.042.7% of flowCommon StockSEC:0001493152-21-026933
1,634 shares@ US$1.840.0026% mcap7.7% of flowCommon StockSEC:0001493152-21-010447:0
1,634 shares@ US$1.847.7% of flowCommon StockSEC:0001493152-21-010447
14 of 14 declarations
About Catelani Michael
Michael Catelani is the Chief Financial Officer and COO at Anixa Biosciences Inc. He is responsible for the financial management of the company, including financial planning, risk management, and financial reporting. His role is essential to ensure the financial health and sustainability of the organization. As President, he also contributes to the strategic direction of the company.
